复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
复星医药(600196) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入3,070,011.912,139,519.261,087,072.084,395,154.693,161,007.13
营业收入3,070,011.912,139,519.261,087,072.084,395,154.693,161,007.13
二、营业总成本3,028,427.922,063,204.191,009,828.444,134,626.442,939,898.09
营业成本1,577,952.121,069,852.05529,479.362,316,969.041,690,792.29
营业税金及附加19,796.2113,757.306,702.1422,779.9416,476.49
销售费用722,668.19507,129.56251,524.87917,117.61648,278.68
管理费用316,893.34204,500.7699,109.25382,810.29261,734.12
财务费用75,607.8854,536.6526,125.6164,740.2737,761.92
研发费用315,510.17213,427.8796,887.22430,209.29284,854.58
资产减值损失----------
公允价值变动收益80,633.6438,737.39-14,760.61-249,836.85-193,077.91
投资收益218,241.73147,338.0776,590.45437,784.26305,347.08
其中:对联营企业和合营企业的投资收益149,592.24102,226.3436,634.49183,514.61122,065.89
汇兑收益----------
三、营业利润334,219.78268,261.08142,713.93465,665.64359,253.28
加:营业外收入4,959.072,420.59562.373,545.911,676.32
减:营业外支出9,933.205,134.674,799.8911,773.3920,645.20
其中:非流动资产处置损失----------
四、利润总额329,245.65265,547.00138,476.40457,438.16340,284.40
减:所得税费用63,864.7061,024.4727,050.9962,691.7561,153.97
五、净利润265,380.95204,522.53111,425.41394,746.41279,130.43
归属于母公司所有者的净利润228,306.59177,747.1998,697.17373,080.46245,436.70
少数股东损益37,074.3626,775.3412,728.2421,665.9533,693.73
六、每股收益
基本每股收益(元/股)0.86000.67000.37001.43000.9500
稀释每股收益(元/股)0.85000.67000.37001.43000.9500
七、其他综合收益38,304.7247,560.58-18,348.6510,804.3545,039.87
八、综合收益总额303,685.68252,083.1193,076.76405,550.76324,170.30
归属于母公司所有者的综合收益总额250,227.09203,629.4883,437.13383,141.45273,013.97
归属于少数股东的综合收益总额53,458.5948,453.639,639.6422,409.3251,156.33
下载全部历史数据到excel中 返回页顶